<span>When converting 3.68 the denominator will be 100.</span>
A+b=6.1 ---(1)
a-b=1.6 ---(2)
(1)+(2); 2a=7.7
then a=3.85
so b=a-1.6 = 3.85-1.6 = 2.25
so that the two numbers are 2.25 and 3.85
Answer:it ends at 11:00
Step-by-step explanation:8:30+2:30=11:00
For the eradication of malignancies like the aggressive type of human brain tumour known as glioblastoma multiforme (GBM), 3D platforms are crucial for tracking tumour growth and assessing treatment candidates.
<h3>What is Glioblastoma Multiforme (GBM)?</h3>
Glioblastoma (GBM), commonly known as a grade IV astrocytoma, is an aggressive brain tumour that grows quickly. The local brain tissue gets invaded, but it typically does not spread to distant organs. GBMs can develop from lower-grade astrocytomas or develop from new brain tumours.
Some characteristics of GBM are-
- We explore cellular behavior, expression profiles of malignancy, and apoptosis-related genes within this novel network using suspension and spheroid-based models of GBM.
- In-depth research is also done on the sensitivity to the anticancer medication Digitoxigenin.
- According to the research, GelMA hydrogels contain high levels of prosurvival Bcl-2 gene expression and sparse or spheroid U373 cells, which have much lower expressions of apoptosis-activating genes like Bad, Puma, and Caspase-3.
- The up regulation of matrix-metalloproteinase genes within GelMA suggests that gels have a beneficial effect on the extracellular remodelling of cancer cells.
- Through the investigation of 3D malignant cancer cell behavior, this special photo curable gelatin shows significant promise for the practical translation of cancer research and, consequently, for more effective treatment techniques for GBM.
To know more about brain tumour, here
brainly.com/question/13606763
#SPJ4
97yards...............................................................................................................................................................................................................................................................................................................
